The 2016 European (EULAR/ERA-EDTA) recommendations for the diagnosis and management of anca-associated systemic vasculitis

In early 2016, the international group of expert members of the European League Against Rheumatism (EULAR), the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA), and the European Vasculitis Society (EUVAS) published new guidelines for the diagnosis and management of antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis (SV). These guidelines are an important step in the development of the concept of ANCA-SV and have resulted from the systematic generalization of current scientific achievements and clinical experience. Fifteen recommendations proposed by the EULAR/ERA-EDTA highlight a wide range of problems of ANCA-SV and should contribute to the improvement of the diagnosis, efficiency of therapy and prognosis of these diseases. The aim of the publication is to provide the general characteristics of the main provisions of the guidelines.